← All trials
NCT00519714
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2007
- Primary completion
- Oct 1, 2008
- Completion date
- Nov 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 195
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of MontrealLead sponsor
- University of British ColumbiaCollaborator
- Manna ResearchCollaborator
- St. Jerome Medical Research Inc.Collaborator
- Cambridge Cardiac Care CentreCollaborator
- Maritime Research CenterCollaborator
- Rhodin Recherche CliniqueCollaborator
- First Line Medical LtdCollaborator
- The Allin ClinicCollaborator
- Recherche Invascor IncCollaborator
- MSHJ Research AssociatesCollaborator
- Dr.Kim W TanCollaborator
- Omnispec Clinical Research Inc, Mirabel, CanadaCollaborator
- University of VirginiaCollaborator
- University of MontrealOverall official - principal investigator
- University of MelbourneCollaborator
- University of TorontoCollaborator
- University of CologneCollaborator
- University of MontrealCollaborator
- University of ParisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.